Kazuhiro Asami

5.6k total citations
61 papers, 1.2k citations indexed

About

Kazuhiro Asami is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kazuhiro Asami has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Kazuhiro Asami's work include Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Kazuhiro Asami is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Kazuhiro Asami collaborates with scholars based in Japan, United States and Indonesia. Kazuhiro Asami's co-authors include Tomoya Kawaguchi, Shinji Atagi, Minoru Takada, Masahiko Ando, Kyoichi Okishio, Tomonori Hirashima, Akihito Kubo, Hideo Saka, Shinzoh Kudoh and Kazuhiko Nakagawa and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Kazuhiro Asami

60 papers receiving 1.2k citations

Peers

Kazuhiro Asami

PRM

ONCOL

EPIDE

Kosuke Tanaka Japan

Sabahattin Cömertpay Türkiye

Aya Sakurai Japan

Sachiko Matsuda Japan

Xuemin Chen China

Guangjian Yang China

Arthur M. Baca United States

Yoshie Takahashi Japan

Keishi Ohtani Japan

Sarah B. Noonberg United States

Kosuke Tanaka Japan

Kazuhiro Asami

829 ×1.0

PRM

608 ×0.8

ONCOL

444 ×1.6

243 ×2.3

170 ×2.3

EPIDE

Citations per year, relative to Kazuhiro Asami Kazuhiro Asami (= 1×) peers Kosuke Tanaka

Countries citing papers authored by Kazuhiro Asami

Since Specialization

Citations

This map shows the geographic impact of Kazuhiro Asami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Asami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Asami more than expected).

Fields of papers citing papers by Kazuhiro Asami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiro Asami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Asami. The network helps show where Kazuhiro Asami may publish in the future.

Co-authorship network of co-authors of Kazuhiro Asami

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Asami. A scholar is included among the top collaborators of Kazuhiro Asami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Asami. Kazuhiro Asami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morimoto, Masahiro, Kyoichi Okishio, Masanori Akira, et al.. (2016). Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer. Clinical Lung Cancer. 18(2). e117–e127. 4 indexed citations

Tamiya, Akihiro, et al.. (2016). Brain Metastasis of Pleural Mesothelioma after a Subarachnoid Hemorrhage. Internal Medicine. 55(7). 779–781. 3 indexed citations

Asami, Kazuhiro, Masaaki Kawahara, Tomonori Hirashima, et al.. (2014). Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non‐squamous cell non‐small cell lung cancer in Japan. Thoracic Cancer. 5(4). 289–296. 2 indexed citations

Omachi, Naoki, Shigeki Shimizu, Tomoya Kawaguchi, et al.. (2014). A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4–ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib. Journal of Thoracic Oncology. 9(6). e40–e42. 45 indexed citations

Isa, Shun‐ichi, Satomi Yamamoto, Akihiro Tamiya, et al.. (2014). Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer. Oncology Letters. 9(2). 927–929. 7 indexed citations

Kawaguchi, Tomoya, Masahiko Ando, Kazuhiro Asami, et al.. (2014). Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA). Journal of Clinical Oncology. 32(18). 1902–1908. 197 indexed citations

Asami, Kazuhiro, et al.. (2014). Dark Anaerobic Hydrogen Production in the Mutants of Synechocystis sp. Strain PCC6803-GT Defective in Lactate Dehydrogenase Activity and/or Alcohol Dehydrogenase Activity, Incubated in Buffer Solutions With or Without Glucose. International Journal of Biology. 7(1). 2 indexed citations

Kanazu, Masaki, Kaoru Maruyama, Masahiko Ando, et al.. (2014). Early Pharmacodynamic Assessment Using 18F-Fluorodeoxyglucose Positron-Emission Tomography on Molecular Targeted Therapy and Cytotoxic Chemotherapy for Clinical Outcome Prediction. Clinical Lung Cancer. 15(3). 182–187. 10 indexed citations

Kawahara, Masaaki, Shinji Atagi, Kiyoshi Komuta, et al.. (2013). Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer.. PubMed. 33(10). 4631–7. 6 indexed citations

10.

Kogure, Yoshihito, Masahiko Ando, Hideo Saka, et al.. (2013). Histology and Smoking Status Predict Survival of Patients with Advanced Non–Small-Cell Lung Cancer: Results of West Japan Oncology Group (WJOG) Study 3906L. Journal of Thoracic Oncology. 8(6). 753–758. 37 indexed citations

11.

Tamiya, Akihiro, Motohiro Tamiya, Takayuki Shiroyama, et al.. (2012). Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer. Annals of Oncology. 24(4). 980–985. 22 indexed citations

12.

Nishie, Kenichi, Tomoya Kawaguchi, Akihiro Tamiya, et al.. (2012). Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations. Journal of Thoracic Oncology. 7(11). 1722–1727. 81 indexed citations

13.

Asami, Kazuhiro, Tomohisa Okuma, Tomonori Hirashima, et al.. (2012). Continued treatment with gefitinib beyond progressive disease benefits patients with activating EGFR mutations. Lung Cancer. 79(3). 276–282. 28 indexed citations

14.

Yamamoto, Takashi, et al.. (2000). 10.51847/lKcKKtW. Time to knit. 4(1). 464–468. 2 indexed citations

15.

Yamamoto, Takashi, et al.. (2000). 10.51847/4fiUS9B. Time to knit. 4(2). 600–603. 1 indexed citations

16.

Asami, Kazuhiro, et al.. (2000). 10.51847/kMWybgI. Time to knit. 5(3). 735–742. 4 indexed citations

17.

Dvorak, James A., Seiichiro Kobayashi, Kazuhiro Asami, et al.. (2000). The application o f the atomic force microscope to studies of medically important protozoan parasites. Journal of Electron Microscopy. 49(3). 429–435. 15 indexed citations

18.

Asami, Kazuhiro, Yasunori Tanji, & Hajime Unno. (2000). Characterization of oxygen-dependent lysis of Escherichia coli cells infected by bacteriophage T4. Journal of Bioscience and Bioengineering. 89(4). 312–317. 1 indexed citations

19.

Yoshikawa, Sayaka, et al.. (1992). Dielectric monitoring of gas production in fermenting bread dough. 69(3). 325–327. 6 indexed citations

20.

Miura, Shunsuke, et al.. (1980). Trichomonas vaginalis: Subcellular localization of NAD+- and NADP+-linked malic enzymes. Kiseichūgaku zasshi. 29(1). 19–26. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact